Cargando…
13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
BACKGROUND: The phytocannabinoid cannabidiol (CBD) attenuates the psychotomimetic effects produced by high doses of delta-9-tetrahydrocannabinol (THC), the main component of the Cannabis sativa plant. Corroborating this effect, several preclinical and clinical studies indicate that CBD has antipsych...
Autores principales: | Guimaraes, Francisco, Rodrigues, Naielly, Silva, Nicole, Gomes, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887392/ http://dx.doi.org/10.1093/schbul/sby014.050 |
Ejemplares similares
-
17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018) -
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016) -
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017) -
Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016) -
Are CB2 Receptors a New Target for Schizophrenia Treatment?
por: Cortez, Isadora L., et al.
Publicado: (2020)